"Of the 2760 women enrolled, all of whom had low-risk, uncomplicated pregnancies, 1381 were randomized to induction at 41 weeks and 1379 to expectant management with induction at 42 weeks. In many centers in the UK and Scandinavia, induction is common no later than 42 weeks." Trial was stopped early because of the higher rate of perinatal mortality in the expectant management group.
This was especially significant in nullips. Read more here.
"Of the 2760 women enrolled, all of whom had low-risk, uncomplicated pregnancies, 1381 were randomized to induction at 41 weeks and 1379 to expectant management with induction at 42 weeks. In many centers in the UK and Scandinavia, induction is common no later than 42 weeks." Trial was stopped early because of the higher rate of perinatal mortality in the expectant management group.
This was especially significant in nullips. Read more here.